[GLP-1 mimetics in clinical studies. Treatment by activation of the GLP-1 receptor].
Ritzel
Robert A
RA
Abteilung Innere Medizin I und Klinische Chemie, Universität Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg. Robert.Ritzel@med.uni-heidelberg.de
D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology*; D000067757:Glucagon-Like Peptide-1 Receptor; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology*; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000502:physiology; D050356:Lipid Metabolism / Q000187:drug effects; D018027:Receptors, Glucagon / Q000819:agonists*; D012038:Regeneration / Q000187:drug effects
C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1; D005947:Glucose